Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, December 13, 2018 · 471,052,129 Articles · 3+ Million Readers

Pharmaceutical Microbiology UK Speaker Interview Released from Fresenius Kabi AB

SMi Report: An exclusive interview with Dr Alex Stoll, Fresenius Kabi, speaker at Pharmaceutical Microbiology UK event can be downloaded on the event website

LONDON, GREATER LONDON, UNITED KINGDOM, November 14, 2018 /EINPresswire.com/ -- In the lead up to the 8th annual Pharmaceutical Microbiology UK Conference taking place in London on 21 and 22 January 2019, SMi organised a speaker interview with our speaker Dr. Alexander Stoll, Vice President, Head of Competence Center Microbiology and Aseptic Techniques, Fresenius Kabi, to discuss the current landscape of pharmaceutical microbiology.

Dr Stoll will be speaking on day one of the conference with her presentation entitled ‘Case Study on using contamination recovery rates to measure performance and improve contamination control'.

Dr. Alexander Stoll completed his PhD thesis in Microbiology/Genetics during September 2001 at the University of Kaiserslautern. After moving to Sweden, he started working in December 2001 for Fresenius Kabi sterile international manufacturing plant in Uppsala, leading a group of microbiologists responsible for microbiological qualification of sterilization processes. In his current position as Vice President Competence Center Microbiology & Aseptic Technique he has built a group of subject matter experts working with all pharmaceutical Fresenius Kabi manufacturing sites and compounding centers, setting global standards. Throughout the years he has gained intensive hands-on experience from different sterile manufacturing techniques for finished medicinal product & API and multiple international authority inspections.

Please see the speaker interview snapshot below:

How would you describe the current challenges in the pharmaceutical microbiology field?
Throughout the last years for sure data integrity has been one of the focus areas for pharmaceutical microbiology. Main focus so far has been how to control & safeguard many of the still manual microbiological processes but also how to better automate some of those processes. I think we are still at an early stage of the automation we have seen in this area so far and I am convinced that automation in the microbiological laboratory will remain a challenge for many years to come.

What developments within contamination control have really caught your eye in the past year?
Especially when it comes to aseptic manufacture of pharmaceuticals there have been many developments into better isolator technologies and more efficient automated decontamination techniques.

For the full exclusive interview with Dr Alexander Stoll, visit the download centre of the event website.

Other topics that will be addressed throughout the programme include: contamination and endotoxins, environmental monitoring, new mechanisms of detection, risk assessments, the current challenge of biofilms, mold contamination challenges, rapid microbial methods and so much more.

Running alongside the conference are two post conference workshops taking place on Wednesday 23rd January 2019, hosted by Microrite and Batelle Memorial Institute and STERIS Corporation.

Morning Workshop on Common Mistakes Made When Setting Up an Environmental Monitoring Programme Led by: Ziva Abraham, CEO, Microrite & Morgan Polen , Contamination Control and Cleanroom Expert, Microrite

Afternoon Workshop on Rapid Microbial Methods & Developing a Risk-Based Cleaning and Disinfection Programme
Led by: Andrew Bartko, Research Leader, Battelle Memorial Institute & Jim Polarine, Senior Technical Service Manager, Steris Corporation

If you are interested in participating and attending the conference, you can register at www.pharma-microbiology.com/EINPR2 and save £200.

Pharmaceutical Microbiology UK is proudly sponsored by Gold Sponsor: DuPont and Sponsors: Mettler Toledo, bioMérieux, Copan Group & Fujifilm
Are you interested in sponsoring, exhibiting or speaking at this event? Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Pharmaceutical Microbiology 2019
21st – 22nd January 2019
Copthorne Tara Hotel. London, UK
www.pharma-microbiology.com/EINPR2

Follow us @SMiPharm
#pharmamicro

---- END ----

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
+1 207-827-6000
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release